16/01/04

The high cost of malaria deaths

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>The high cost of malaria deaths</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p><P>Outdated drugs are helping fuel a rise in malaria worldwide, according to an international group of experts writing in <em>The Lancet</em>. They say that although effective treatments are available, pressure on the World Health Organisation (WHO) to cut costs means that the vast majority of patients are given old treatments — to which many are now resistant.</P><br />
<P>Through its Roll Back Malaria campaign, the WHO aims to halve deaths from the disease — which kills a million people a year — by 2010. But it acknowledges that the burden of malaria is increasing.</P><br />
<P>While the WHO itself recommends the newer artemisinin-class combination therapies (ACT), which can successfully treat 90 per cent of more of patients, these are costly in comparison to the older drugs such as chloroquine. Poor countries asking the WHO-backed Global Fund to pay for ACT are often refused, and forced to accept the older drugs, say the authors. Tens of thousands of children are dying every year as a direct result of these decisions, they say. </P><br />
<P>The group is calling for the WHO to publish guidelines for treatment.</P><br />
<P><a  href="http://www.thelancet.com/journal/vol363/iss9404/full/llan.363.9404.editorial_and_review.28398.1" target="_blank" onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" rel="noopener noreferrer">Link to opinion article in <EM>The Lancet</EM></A>* <BR></P><br />
<P><a  href="http://www.thelancet.com/journal/vol363/iss9406/full/llan.363.9406.correspondence.28581.1" target="_blank" onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" rel="noopener noreferrer">Link to response from the World Health Organisation in <em>The Lancet</em></A>*<BR><BR>* Free registration is required to view these articles</P><br />
<P>Reference: <em>The Lancet</em> 363, 237 (2004)</P></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/opinions/the-high-cost-of-malaria-deaths/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/opinions/the-high-cost-of-malaria-deaths/",null,true])
</script>
</div>

Outdated drugs are helping fuel a rise in malaria worldwide, according to an international group of experts writing in The Lancet. They say that although effective treatments are available, pressure on the World Health Organisation (WHO) to cut costs means that the vast majority of patients are given old treatments — to which many are now resistant.

Through its Roll Back Malaria campaign, the WHO aims to halve deaths from the disease — which kills a million people a year — by 2010. But it acknowledges that the burden of malaria is increasing.

While the WHO itself recommends the newer artemisinin-class combination therapies (ACT), which can successfully treat 90 per cent of more of patients, these are costly in comparison to the older drugs such as chloroquine. Poor countries asking the WHO-backed Global Fund to pay for ACT are often refused, and forced to accept the older drugs, say the authors. Tens of thousands of children are dying every year as a direct result of these decisions, they say.

The group is calling for the WHO to publish guidelines for treatment.

Link to opinion article in The Lancet*

Link to response from the World Health Organisation in The Lancet*

* Free registration is required to view these articles

Reference: The Lancet 363, 237 (2004)